First Manhattan’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

First Manhattan’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-7	Closed	–	–	1447
2018 Q1	$0	Buy	+7	New	+$614	﹤0.01%	1501

Other funds holding TTPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Manhattan's TTPH Position: Q2 2018 in Review

First Manhattan sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2018, closing a stake of 7 shares.

First Manhattan first reported a position in TTPH in Q1 2018 and held it in 1 quarter. The position peaked at $0 in Q1 2018. 90 funds tracked by Wall St. Rank hold TTPH as of Q2 2018.

First Manhattan reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
First Manhattan sold 7 Tetraphase Pharmaceuticals, Inc. shares in Q2 2018.
First Manhattan first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2018 and held it in 1 quarter.
First Manhattan's Tetraphase Pharmaceuticals, Inc. position peaked at $0 in Q1 2018.
90 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2018.

Based on First Manhattan's 13F filing for Q2 2018, filed 1 Aug 2018.